Vanguard Group Inc Lyra Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,787,422 shares of LYRA stock, worth $357,484. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,787,422
Previous 1,779,263
0.46%
Holding current value
$357,484
Previous $462,000
18.83%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding LYRA
# of Institutions
54Shares Held
26.2MCall Options Held
21KPut Options Held
0-
Perceptive Advisors LLC New York, NY12.8MShares$2.55 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$565,9950.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA1.97MShares$393,1370.13% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$211,6290.04% of portfolio
-
Geode Capital Management, LLC Boston, MA886KShares$177,1930.0% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $6.37M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...